Page 84 - Micron News Today

Researchers longitudinally isolated immensely potent monoclonal antibodies from macaques vaccinated with COVID-19.

Amid the surge of the Omicron wave and to avoid a repeat of previous two years, the CBSE, in a first, decided to conduct the exams in two terms in 2022. The first term was conducted in objective format and the second in subjective format

Researchers reported the increased transmissibility of the severe acute respiratory syndrome coronavirus 2.

Researchers assess whether nirmatrelvir/ritonavir treatment reduced the risk of COVID-19-related hospitalization.

The end of the national COVID-19 public health emergency will usher in changes that the public will likely notice when it comes to out-of-pocket costs.

Researchers explore the presence and effectiveness of SARS-CoV-2 antibodies in breastmilk following infection, vaccination, or both.

Research paper reports on a study conducted in Sweden to determine the prevalence of SARS-CoV-2 Omicron infection despite high seroprevalence. The study found a high prevalence of SARS-CoV-2 Omicron infection in Sweden despite high seroprevalence.

New York needs to get moving on climate action — our small businesses are counting on it.

New Omicron subvariant XBB.1.16 continues to spread rapidly in the United States, with its prevalence increasing to 12.5 percent

In a recent study published in the JAMA Network Open, researchers performed a systematic review and meta-analysis using secondary data from 40 published studies reporting time-varying, population-level coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) estimates against laboratory-confirmed infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, Omicron or Delta, and symptomatic disease.